Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.
Autor: | Dos Santos, Gaël1 (AUTHOR) gael.x.dos-santos@gsk.com, Wang, Hao2 (AUTHOR), Jindal, Pooja3 (AUTHOR), Rybo, Maria4 (AUTHOR), Roul, Hélène5 (AUTHOR), Pallem, Sridevi6 (AUTHOR), Eckermann, Tamara7 (AUTHOR), Godderis, Lode8,9 (AUTHOR), Martínez Gómez, Xavier10 (AUTHOR), Godard, Eric11 (AUTHOR), Soler, Muriel12 (AUTHOR), Yousefi, Mitra13 (AUTHOR), Salamanca de la Cueva, Ignacio14 (AUTHOR), Nwoji, Ugo13 (AUTHOR) |
---|---|
Zdroj: | Infectious Diseases & Therapy. Feb2022, Vol. 11 Issue 1, p463-483. 21p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |